Preterm Birth
1
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
BayerLEVERKUSEN, Germany
1 programDirect Measurements of Cervical Remodeling for Predicting Preterm BirthN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
Hamilton medicalCelestone + placebo
BayerDirect Measurements of Cervical Remodeling for Predicting Preterm Birth
PfizerTriadic parent-infant Relationship Therapy
Clinical Trials (3)
Total enrollment: 1,296 patients across 3 trials
Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)
Start: Jul 2023Est. completion: Dec 2029
Phase 4Recruiting
Direct Measurements of Cervical Remodeling for Predicting Preterm Birth
Start: Nov 2009Est. completion: May 20121,207 patients
N/ACompleted
Impact of an Intervention Program on Parenting Stress After Preterm Birth
Start: Jun 2006Est. completion: Feb 201089 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 1,296 patients
3 companies competing in this space